NIBEC Co. Ltd
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more
Market Cap & Net Worth: NIBEC Co. Ltd (138610)
NIBEC Co. Ltd (KQ:138610) has a market capitalization of $223.58 Million (₩327.37 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #15752 globally and #473 in its home market, demonstrating a 1.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NIBEC Co. Ltd's stock price ₩28950.00 by its total outstanding shares 11307992 (11.31 Million).
NIBEC Co. Ltd Market Cap History: 2015 to 2026
NIBEC Co. Ltd's market capitalization history from 2015 to 2026. Data shows growth from $69.61 Million to $223.58 Million (11.75% CAGR).
Index Memberships
NIBEC Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.10% | #172 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.10% | #172 of 1384 |
Weight: NIBEC Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NIBEC Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NIBEC Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
NIBEC Co. Ltd's market cap is 0.01 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $69.61 Million | $4.17 Billion | -$2.43 Billion | 0.02x | N/A |
| 2016 | $50.50 Million | $4.80 Billion | -$3.03 Billion | 0.01x | N/A |
| 2017 | $67.96 Million | $6.30 Billion | -$2.57 Billion | 0.01x | N/A |
| 2018 | $71.25 Million | $5.21 Billion | -$4.15 Billion | 0.01x | N/A |
| 2019 | $85.72 Million | $9.29 Billion | -$2.73 Billion | 0.01x | N/A |
| 2020 | $334.40 Million | $6.36 Billion | -$3.64 Billion | 0.05x | N/A |
| 2021 | $225.12 Million | $13.63 Billion | -$5.74 Billion | 0.02x | N/A |
| 2022 | $146.35 Million | $21.67 Billion | -$3.77 Billion | 0.01x | N/A |
| 2023 | $167.20 Million | $15.70 Billion | -$6.28 Billion | 0.01x | N/A |
| 2024 | $123.41 Million | $24.55 Billion | -$9.33 Billion | 0.01x | N/A |
Competitor Companies of 138610 by Market Capitalization
Companies near NIBEC Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to NIBEC Co. Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
NIBEC Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, NIBEC Co. Ltd's market cap moved from $69.61 Million to $ 223.58 Million, with a yearly change of 11.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩223.58 Million | -22.90% |
| 2025 | ₩290.00 Million | +134.98% |
| 2024 | ₩123.41 Million | -26.19% |
| 2023 | ₩167.20 Million | +14.25% |
| 2022 | ₩146.35 Million | -34.99% |
| 2021 | ₩225.12 Million | -32.68% |
| 2020 | ₩334.40 Million | +290.09% |
| 2019 | ₩85.72 Million | +20.32% |
| 2018 | ₩71.25 Million | +4.83% |
| 2017 | ₩67.96 Million | +34.59% |
| 2016 | ₩50.50 Million | -27.45% |
| 2015 | ₩69.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NIBEC Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $223.58 Million USD |
| MoneyControl | $223.58 Million USD |
| MarketWatch | $223.58 Million USD |
| marketcap.company | $223.58 Million USD |
| Reuters | $223.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.